Form D · Hedge Fund

OrbiMed Partners II, L.P.

New York, NY · CIK 0001324240

Offering snapshot reported Jul 10, 2026 · SEC filing

Reported sold: $1.78B
Investors reported: 880
Minimum accepted: $0
First sale: Jun 1, 1998

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$215,514,926 → $1,779,469,650
Reported investors79 → 880

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 10, 2026	Amendment	$1,779,469,650	$1,563,954,724vs Mar 12, 2010	880	SEC filing
Jul 10, 2025	Amendment	$1,779,469,650	$1,563,954,724vs Mar 12, 2010	880	SEC filing
Jul 12, 2024	Amendment	$1,779,469,650	$1,563,954,724vs Mar 12, 2010	880	SEC filing
Jul 12, 2023	Amendment	$1,779,469,650	$1,563,954,724vs Mar 12, 2010	880	SEC filing
Jul 14, 2022	Amendment	$1,778,719,650	$1,563,204,724vs Mar 12, 2010	880	SEC filing
Jul 16, 2021	Amendment	$1,770,099,650	$1,554,584,724vs Mar 12, 2010	874	SEC filing
Jul 16, 2020	Amendment	$1,749,614,118	$1,534,099,192vs Mar 12, 2010	849	SEC filing
Jul 16, 2019	Amendment	$1,738,864,013	$1,523,349,087vs Mar 12, 2010	842	SEC filing
Jul 16, 2018	Amendment	$1,714,214,013	$1,498,699,087vs Mar 12, 2010	835	SEC filing
Jul 14, 2017	Amendment	$1,643,696,853	$1,428,181,927vs Mar 12, 2010	797	SEC filing
Jul 14, 2016	Amendment	$1,565,361,853	$1,349,846,927vs Mar 12, 2010	744	SEC filing
Jul 14, 2015	Amendment	$1,346,181,853	$1,130,666,927vs Mar 12, 2010	624	SEC filing
Jul 14, 2014	Amendment	$1,142,846,853	$927,331,927vs Mar 12, 2010	528	SEC filing
Jul 12, 2013	Amendment	$836,672,000	$621,157,074vs Mar 12, 2010	372	SEC filing
Mar 12, 2013	Amendment	$640,107,000	$424,592,074vs Mar 12, 2010	299	SEC filing
Mar 12, 2012	Amendment	$446,081,853	$230,566,927vs Mar 12, 2010	209	SEC filing
Mar 11, 2011	Amendment	$236,139,926	$20,625,000vs Mar 12, 2010	91	SEC filing
Mar 12, 2010	Amendment	$215,514,926	No comparison	79	SEC filing
Mar 13, 2009	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $30.9M (estimated)
Finders' fees: $0
Form D file number: 021-128771

Subject to future contingencies.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Far Hills Group, LLC	000032243

Source: Form D, filed Jul 10, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED PARTNERS II, L.P.

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value: $2.1B
Beneficial owners: 541
ADV minimum commitment: $1M

Reported in Form ADV on May 21, 2018. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV (CAYMAN) LTD. GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP NEW YORK, New York, United States

Custodian BARCLAYS BANK PLC EBENE, Mauritius Related to adviser: No

Custodian CITIBANK (CHINA) CO., LTD. SHANGHAI, China Related to adviser: No

Custodian CITIBANK N.A. MUMBAI, India Related to adviser: No

Custodian GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No

Custodian GOLDMAN SACHS INTERNATIONAL LONDON, United Kingdom Related to adviser: No

Custodian J.P. MORGAN CLEARING CORP. BROOKLYN, New York, United States Related to adviser: No

Custodian THE NORTHERN TRUST INTERNATIONAL BANKING CORPORATION JERSEY CITY, New Jersey, United States Related to adviser: No

Custodian U.S. BANK NEW YORK, New York, United States Related to adviser: No

Marketer FAR HILLS GROUP, LLC. NEW YORK, New York, United States Related to adviser: No

Marketer J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Prime broker GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States

Prime broker J.P. MORGAN CLEARING CORP. BROOKLYN, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG LLP
PCAOB 185

GOLDMAN SACHS & CO. LLC
SEC 8-129

J.P. MORGAN CLEARING CORP.
SEC 8-43724

FAR HILLS GROUP, LLC.
CRD 32243 · SEC 8-45675

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 801-3702

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

J.P. MORGAN CLEARING CORP.
CRD 28432 · SEC 8-43724

Filing source

Form ADV 1219257 · May 21, 2018 · Schedule D 7.B.(1), fund 805-1051414574

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Mona Ashiya	Executive
David Bonita	Executive
Sven H. Borho	Executive
Carl L. Gordon	Executive
Geoffrey C. Hsu	Executive
Samuel D. Isaly	Executive
W. Carter Neild	Executive
Orbi Med Advisors Llc	Executive, Promoter
Matthew S. Rizzo	Executive
Michael B. Sheffery	Executive, Promoter
Jonathan T. Silverstein	Executive
C. Scotland Stevens	Executive
Peter A. Thompson	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

601 Lexington Avenue, 54 Th Floor
New York, NY, 10022